应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SLDB Solid Biosciences
休市中 09-11 16:00:00 EDT
8.70
-0.37
-4.08%
盘后
8.70
+0.00
0.00%
19:59 EDT
最高
9.37
最低
8.66
成交量
111.39万
今开
9.21
昨收
9.07
日振幅
7.83%
总市值
9.33亿
流通市值
5.64亿
总股本
1.07亿
成交额
982.01万
换手率
1.72%
流通股本
6,481万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Solid Biosciences与Nanomosaic宣布达成联合营销协议,共促基因疗法递送与分析技术发展
美股速递 · 06-02
Solid Biosciences与Nanomosaic宣布达成联合营销协议,共促基因疗法递送与分析技术发展
Solid Biosciences启动SGT-003治疗杜氏肌营养不良症的三期临床试验,完成首例患者给药
美股速递 · 05-07
Solid Biosciences启动SGT-003治疗杜氏肌营养不良症的三期临床试验,完成首例患者给药
Solid Biosciences宣布SGT-003获欧盟委员会授予杜氏肌营养不良症孤儿药资格认定
美股速递 · 04-28
Solid Biosciences宣布SGT-003获欧盟委员会授予杜氏肌营养不良症孤儿药资格认定
Solid Biosciences提交转售说明书 股东拟最高减持130万股
美股速递 · 03-20
Solid Biosciences提交转售说明书 股东拟最高减持130万股
Solid Biosciences公布2025年第四季度及全年财报并更新业务进展
美股速递 · 03-20
Solid Biosciences公布2025年第四季度及全年财报并更新业务进展
Solid Biosciences Inc.盘中异动 股价大跌5.07%报5.15美元
市场透视 · 2025-03-10
Solid Biosciences Inc.盘中异动 股价大跌5.07%报5.15美元
Solid Biosciences Inc.2024财年实现净利润-1.25亿美元,同比减少30.18%
市场透视 · 2025-03-10
Solid Biosciences Inc.2024财年实现净利润-1.25亿美元,同比减少30.18%
Solid Biosciences(SLDB.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-1.00美元,前值为-1.01美元,预期值为-0.72美元。
金融界 · 2025-03-07
Solid Biosciences(SLDB.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-1.00美元,前值为-1.01美元,预期值为-0.72美元。
Solid Biosciences 2024年第四季度GAAP每股收益$(1.00) 未达预期$(0.81)
财报速递 · 2025-03-07
Solid Biosciences 2024年第四季度GAAP每股收益$(1.00) 未达预期$(0.81)
Solid Biosciences Inc.盘中异动 股价大涨5.08%报5.58美元
市场透视 · 2025-03-05
Solid Biosciences Inc.盘中异动 股价大涨5.08%报5.58美元
Solid Biosciences Inc.盘中异动 早盘快速上涨5.27%报5.58美元
市场透视 · 2025-02-19
Solid Biosciences Inc.盘中异动 早盘快速上涨5.27%报5.58美元
Solid Biosciences Inc.盘中异动 股价大涨65.63%
市场透视 · 2025-02-18
Solid Biosciences Inc.盘中异动 股价大涨65.63%
Solid Biosciences盘前暴涨,一种新疗法取得良好实验效果
老虎资讯综合 · 2025-02-18
Solid Biosciences盘前暴涨,一种新疗法取得良好实验效果
Solid Biosciences Inc.盘中异动 早盘股价大涨5.10%报3.71美元
市场透视 · 2025-02-13
Solid Biosciences Inc.盘中异动 早盘股价大涨5.10%报3.71美元
Solid Biosciences Inc.盘中异动 早盘股价大跌5.23%
市场透视 · 2025-02-11
Solid Biosciences Inc.盘中异动 早盘股价大跌5.23%
Solid Biosciences Inc.股价上涨25.00% 市值涨3595.93万美元
市场透视 · 2025-02-10
Solid Biosciences Inc.股价上涨25.00% 市值涨3595.93万美元
Solid Biosciences Inc.盘中异动 股价大涨5.59%
市场透视 · 2025-02-07
Solid Biosciences Inc.盘中异动 股价大涨5.59%
Solid Biosciences Inc.盘中异动 股价大跌5.24%
市场透视 · 2025-02-05
Solid Biosciences Inc.盘中异动 股价大跌5.24%
Solid Biosciences Inc.盘中异动 大幅下跌5.03%报3.02美元
市场透视 · 2025-02-03
Solid Biosciences Inc.盘中异动 大幅下跌5.03%报3.02美元
Solid Biosciences Inc.盘中异动 大幅跳水5.10%
市场透视 · 2025-01-28
Solid Biosciences Inc.盘中异动 大幅跳水5.10%
加载更多
公司概况
公司名称:
Solid Biosciences
所属市场:
NASDAQ
上市日期:
--
主营业务:
Solid Biosciences Inc.前称是“SOLID Ventures Management, LLC”,成立于2013年3月,最初是作为一家特拉华州有限责任公司成立的。该公司是一家生命科学公司,专注于推进当前和未来基因治疗候选药物组合,该公司将其统称为候选药物,包括用于治疗杜氏肌营养不良症的SGT-003,或Duchenne,用于治疗儿茶酚胺能多形性室性心动过速(CPVT)的SGT-501,以及用于治疗心脏和疾病的额外资产,处于不同的发展阶段,投资水平不同。该公司正在推进涉及罕见神经肌肉和心脏疾病的多样化管道,汇集科学、技术、疾病管理和护理方面的专家。以患者为中心,由直接受到Duchenne影响的人创立,该公司的使命是改善患有这些毁灭性疾病的患者的日常生活。
发行价格:
--
{"stockData":{"symbol":"SLDB","market":"US","secType":"STK","nameCN":"Solid Biosciences","latestPrice":8.7,"timestamp":1789156800000,"preClose":9.07,"halted":0,"volume":1113857,"hourTrading":{"tag":"盘后","latestPrice":8.7,"preClose":8.7,"latestTime":"19:59 EDT","volume":12767,"amount":111192.01,"timestamp":1789171170703,"change":0,"changeRate":0,"amplitude":0.004598},"delay":0,"changeRate":-0.04079382579933859,"floatShares":64811899,"shares":107225238,"eps":-1.870908,"marketStatus":"休市中","change":-0.37,"latestTime":"09-11 16:00:00 EDT","open":9.205,"high":9.365,"low":8.655,"amount":9820147.592665,"amplitude":0.07828,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.870908,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1516942800000,"exchange":"NASDAQ","adjPreClose":9.07,"preHourTrading":{"tag":"盘前","latestPrice":9.23,"preClose":9.07,"latestTime":"09:29 EDT","volume":1013,"amount":9194.958454,"timestamp":1789133342039,"change":0.16,"changeRate":0.017641,"amplitude":0.025358},"postHourTrading":{"tag":"盘后","latestPrice":8.7,"preClose":8.7,"latestTime":"19:59 EDT","volume":12767,"amount":111192.01,"timestamp":1789171170703,"change":0,"changeRate":0,"amplitude":0.004598},"volumeRatio":1.605495767012606,"impliedVol":1.1331,"impliedVolPercentile":0.5259},"requestUrl":"/m/hq/s/SLDB","defaultTab":"news","newsList":[{"id":"1147512603","title":"Solid Biosciences与Nanomosaic宣布达成联合营销协议,共促基因疗法递送与分析技术发展","url":"https://stock-news.laohu8.com/highlight/detail?id=1147512603","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147512603?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:01","pubTimestamp":1780398119,"startTime":"0","endTime":"0","summary":"Solid Biosciences与Nanomosaic近日共同宣布,双方已签署一项联合营销协议,旨在携手推进基因治疗领域的递送技术与分析方案的进步。这一合作将整合双方的专业优势,共同开发并推广创新的解决方案,以应对基因疗法在精准递送与高效分析方面所面临的挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLDB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151595680","title":"Solid Biosciences启动SGT-003治疗杜氏肌营养不良症的三期临床试验,完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1151595680","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151595680?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:03","pubTimestamp":1778155406,"startTime":"0","endTime":"0","summary":"生物技术公司Solid Biosciences(股票代码:SLDB)宣布,其在研基因疗法SGT-003针对杜氏肌营养不良症(DMD)的三期临床试验“IMPACT Duchenne”已完成首例患者给药。这标志着该疗法临床开发进入关键阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLDB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185009877","title":"Solid Biosciences宣布SGT-003获欧盟委员会授予杜氏肌营养不良症孤儿药资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1185009877","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185009877?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:02","pubTimestamp":1777377757,"startTime":"0","endTime":"0","summary":"生物技术公司Solid Biosciences近日宣布,其针对杜氏肌营养不良症研发的基因治疗候选药物SGT-003,已正式获得欧盟委员会颁发的孤儿药资格认定。这一认定标志着该疗法在欧盟地区药物开发进程中的重要监管进展。SGT-003作为该公司基因治疗管线的重要候选药物,此次获得欧盟监管机构的认可,为其在欧洲市场的战略布局奠定了坚实基础。该认定将加速推进SGT-003在全球范围内的临床开发计划,为杜氏肌营养不良症患者提供新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLDB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158258589","title":"Solid Biosciences提交转售说明书 股东拟最高减持130万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1158258589","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158258589?lang=zh_cn&edition=full","pubTime":"2026-03-20 05:05","pubTimestamp":1773954314,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新披露文件,生物科技公司Solid Biosciences已提交转售说明书,公司某持股股东计划最高转售130万股普通股。\n此次备案为后续市场交易提供法律依据,转售规模约占公司流通股本的一定比例。文件显示该交易将通过公开市场渠道进行,具体出售时间与价格将根据市场情况确定。\n作为专注基因疗法研发的生物制药企业,Solid Biosciences近期股价波动较大。本次股东减持计划可能对二级市场流动性产生一定影响,投资者需关注后续持股变动情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLDB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131831762","title":"Solid Biosciences公布2025年第四季度及全年财报并更新业务进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1131831762","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131831762?lang=zh_cn&edition=full","pubTime":"2026-03-20 04:13","pubTimestamp":1773951193,"startTime":"0","endTime":"0","summary":"Solid Biosciences近日披露了2025年第四季度及全年的财务业绩报告,同时分享了公司最新的业务动态。此次公布涵盖了公司在财务表现和战略推进方面的关键信息,展现了企业当前的发展态势与未来规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLDB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518275986","title":"Solid Biosciences Inc.盘中异动 股价大跌5.07%报5.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518275986?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:31","pubTimestamp":1741617063,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时31分,Solid Biosciences Inc.股票出现波动,股价快速跳水5.07%。截至发稿,该股报5.15美元/股,成交量21.2482万股,换手率0.28%,振幅8.20%。Solid Biosciences Inc.股票所在的生物技术行业中,整体涨幅为0.08%。其相关个股中,Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃,换手率分别为3458.13%、731.09%、517.88%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.,振幅分别为41.36%、40.33%、40.24%。Solid Biosciences Inc.公司简介:Solid Biosciences Inc 是一家生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223103abf312b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223103abf312b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLDB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518281162","title":"Solid Biosciences Inc.2024财年实现净利润-1.25亿美元,同比减少30.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518281162","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518281162?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536087,"startTime":"0","endTime":"0","summary":"3月10日,Solid Biosciences Inc.公布财报,公告显示公司2024财年净利润为-1.25亿美元,同比减少30.18%;其中营业收入为0.00美元,每股基本收益为-3.06美元。从资产负债表来看,Solid Biosciences Inc.总负债51.42百万美元,其中短期债务3.02百万美元,资产负债比为0.04,流动比率为0.06。机构评级:截至2025年3月10日,当前有9家机构对Solid Biosciences Inc.目标价做出预测,其中目标均价为16.89美元,其中最低目标价为15.00美元,最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000312abf17590&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000312abf17590&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLDB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517114307","title":"Solid Biosciences(SLDB.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-1.00美元,前值为-1.01美元,预期值为-0.72美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517114307","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517114307?lang=zh_cn&edition=full","pubTime":"2025-03-07 06:41","pubTimestamp":1741300899,"startTime":"0","endTime":"0","summary":"Solid Biosciences(SLDB.US):2024年Q4财报实现营收0美元,前值为0美元;每股收益为-1.00美元,前值为-1.01美元,预期值为-0.72美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07064148578813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SLDB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128396485","title":"Solid Biosciences 2024年第四季度GAAP每股收益$(1.00) 未达预期$(0.81)","url":"https://stock-news.laohu8.com/highlight/detail?id=1128396485","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128396485?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:30","pubTimestamp":1741296630,"startTime":"0","endTime":"0","summary":"Solid Biosciences报告季度亏损$每股,未达到分析师预期的$,差23.46%。这比去年同期每股亏损$增加了0.99%。以上内容来自Benzinga Earnings专栏,原文如下:$Solid Biosciences$ reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 23.46 percent. This is a 0.99 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Solid Biosciences 2024年第四季度GAAP每股收益$(1.00) 未达预期$(0.81)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLDB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517946934","title":"Solid Biosciences Inc.盘中异动 股价大涨5.08%报5.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517946934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517946934?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:35","pubTimestamp":1741188952,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时35分,Solid Biosciences Inc.股票出现波动,股价急速上涨5.08%。截至发稿,该股报5.58美元/股,成交量21.0671万股,换手率0.28%,振幅6.69%。Solid Biosciences Inc.股票所在的生物技术行业中,整体涨幅为1.21%。其相关个股中,Chimerix, Inc.、Nutriband Inc C/Wts 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大,Silexion Therapeutics Corp、Tc Biopharm Plc、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为866.19%、286.69%、264.09%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Nkgen Biotech, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ,振幅分别为54.27%、42.66%、41.26%。Solid Biosciences Inc.公司简介:Solid Biosciences Inc 是一家生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233552963aecf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233552963aecf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLDB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512485455","title":"Solid Biosciences Inc.盘中异动 早盘快速上涨5.27%报5.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512485455?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:31","pubTimestamp":1739975496,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时31分,Solid Biosciences Inc.股票出现异动,股价大幅拉升5.27%。截至发稿,该股报5.58美元/股,成交量38.4692万股,换手率0.96%,振幅4.62%。Solid Biosciences Inc.股票所在的生物技术行业中,整体跌幅为0.15%。其相关个股中,Osr Holdings, Inc.、Aditxt, Inc.、Citius Pharmaceuticals, Inc.涨幅较大,Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃,换手率分别为206.33%、202.22%、65.58%,振幅较大的相关个股有Osr Holdings, Inc.、Azitra Inc、2Seventy Bio, Inc.,振幅分别为21.86%、11.29%、7.53%。Solid Biosciences Inc.公司简介:Solid Biosciences Inc 是一家生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223136a24bf95e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223136a24bf95e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLDB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512404165","title":"Solid Biosciences Inc.盘中异动 股价大涨65.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512404165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512404165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889060,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分,Solid Biosciences Inc.股票出现异动,股价大幅上涨65.63%。截至发稿,该股报6.68美元/股,成交量3616.09万股,换手率90.50%,振幅0.37%。Solid Biosciences Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大,Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为275.19%、90.58%、58.67%,振幅较大的相关个股有Allakos Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.,振幅分别为6.84%、6.43%、6.13%。Solid Biosciences Inc.公司简介:Solid Biosciences Inc 是一家生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223100a24aac39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223100a24aac39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLDB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166814570","title":"Solid Biosciences盘前暴涨,一种新疗法取得良好实验效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1166814570","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166814570?lang=zh_cn&edition=full","pubTime":"2025-02-18 21:34","pubTimestamp":1739885685,"startTime":"0","endTime":"0","summary":"寻求该药物加速获批。","market":"us","thumbnail":"https://static.tigerbbs.com/9269b3320f1db7905b8c8354969850a6","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9269b3320f1db7905b8c8354969850a6"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Solid Biosciences针对杜氏肌营养不良症的新疗法取得良好实验效果","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLDB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511978529","title":"Solid Biosciences Inc.盘中异动 早盘股价大涨5.10%报3.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511978529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511978529?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:06","pubTimestamp":1739459197,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时06分,Solid Biosciences Inc.股票出现波动,股价大幅上涨5.10%。截至发稿,该股报3.71美元/股,成交量11.8218万股,换手率0.30%,振幅4.81%。Solid Biosciences Inc.股票所在的生物技术行业中,整体涨幅为0.18%。其相关个股中,Edesa Biotech, Inc.、Enanta Pharmaceuticals, Inc.、Nutriband Inc C/Wts 涨幅较大,Edesa Biotech, Inc.、Tc Biopharm Plc、Genprex, Inc.较为活跃,换手率分别为1663.49%、1111.53%、128.23%,振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Edesa Biotech, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ,振幅分别为92.30%、73.65%、32.86%。Solid Biosciences Inc.公司简介:Solid Biosciences Inc 是一家生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132306379884334c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132306379884334c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLDB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510382853","title":"Solid Biosciences Inc.盘中异动 早盘股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510382853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510382853?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:07","pubTimestamp":1739286420,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时07分,Solid Biosciences Inc.股票出现异动,股价急速下挫5.23%。截至发稿,该股报3.26美元/股,成交量22.4576万股,换手率0.56%,振幅4.94%。Solid Biosciences Inc.股票所在的生物技术行业中,整体跌幅为1.38%。其相关个股中,Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为2504.47%、737.51%、329.04%,振幅较大的相关个股有Dominari Holdings Inc.、In8Bio, Inc.、Ocean Biomedical, Inc.,振幅分别为52.11%、37.99%、37.16%。Solid Biosciences Inc.公司简介:Solid Biosciences Inc 是一家生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112307009881c404&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112307009881c404&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLDB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510865634","title":"Solid Biosciences Inc.股价上涨25.00% 市值涨3595.93万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510865634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510865634?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:31","pubTimestamp":1739197915,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分,Solid Biosciences Inc.股票出现异动,股价大幅拉升25.00%。截至发稿,该股报3.60美元/股,成交量51.8766万股,换手率1.30%,振幅1.04%。Solid Biosciences Inc.股票所在的生物技术行业中,整体涨幅为0.38%。其相关个股中,Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃,换手率分别为1485.71%、837.39%、552.06%,振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Nls Pharmaceutics Ltd.,振幅分别为12.29%、8.65%、7.48%。Solid Biosciences Inc.公司简介:Solid Biosciences Inc 是一家生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223155a240a201&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223155a240a201&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLDB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509204172","title":"Solid Biosciences Inc.盘中异动 股价大涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509204172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509204172?lang=zh_cn&edition=full","pubTime":"2025-02-07 01:35","pubTimestamp":1738863338,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日01时35分,Solid Biosciences Inc.股票出现波动,股价急速拉升5.59%。截至发稿,该股报3.21美元/股,成交量15.2986万股,换手率0.38%,振幅4.93%。Solid Biosciences Inc.股票所在的生物技术行业中,整体跌幅为0.19%。其相关个股中,Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃,换手率分别为6289.76%、1645.44%、165.02%,振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为125.58%、58.78%、53.02%。Solid Biosciences Inc.公司简介:Solid Biosciences Inc 是一家生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207013539a23bf4d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207013539a23bf4d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLDB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509491434","title":"Solid Biosciences Inc.盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509491434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509491434?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:51","pubTimestamp":1738702308,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时51分,Solid Biosciences Inc.股票出现异动,股价快速跳水5.24%。截至发稿,该股报2.99美元/股,成交量32.6627万股,换手率0.82%,振幅8.25%。Solid Biosciences Inc.股票所在的生物技术行业中,整体涨幅为1.46%。其相关个股中,Mink Therapeutics, Inc.、Cingulate Inc C/Wts 10/12/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为1965.08%、995.90%、590.80%,振幅较大的相关个股有Azitra Inc、Mink Therapeutics, Inc.、Omega Therapeutics, Inc.,振幅分别为123.99%、74.13%、59.42%。Solid Biosciences Inc.公司简介:Solid Biosciences Inc 是一家生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205045148abc26d5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205045148abc26d5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLDB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508141859","title":"Solid Biosciences Inc.盘中异动 大幅下跌5.03%报3.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508141859?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:37","pubTimestamp":1738593441,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时37分,Solid Biosciences Inc.股票出现波动,股价急速跳水5.03%。截至发稿,该股报3.02美元/股,成交量1.1948万股,换手率0.03%,振幅1.67%。Solid Biosciences Inc.股票所在的生物技术行业中,整体跌幅为0.40%。其相关个股中,Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大,Hcw Biologics Inc.、Cyclerion Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为367.79%、152.19%、54.98%,振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.,振幅分别为82.17%、33.33%、27.90%。Solid Biosciences Inc.公司简介:Solid Biosciences Inc 是一家生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223721a2380b37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223721a2380b37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLDB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506514623","title":"Solid Biosciences Inc.盘中异动 大幅跳水5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506514623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506514623?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:36","pubTimestamp":1738074964,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时36分,Solid Biosciences Inc.股票出现异动,股价快速下挫5.10%。截至发稿,该股报2.98美元/股,成交量2.4096万股,换手率0.06%,振幅4.14%。Solid Biosciences Inc.股票所在的生物技术行业中,整体跌幅为0.05%。其相关个股中,Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Hepion Pharmaceuticals, Inc.涨幅较大,Hepion Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为770.43%、223.72%、152.92%,振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Allarity Therapeutics, Inc.、Telomir Pharmaceuticals, Inc.,振幅分别为113.08%、103.25%、100.74%。Solid Biosciences Inc.公司简介:Solid Biosciences Inc 是一家生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223604a2326fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223604a2326fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SLDB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.solidbio.com","stockEarnings":[{"period":"1week","weight":-0.1512},{"period":"1month","weight":-0.0403},{"period":"3month","weight":0.2185},{"period":"6month","weight":0.1902},{"period":"1year","weight":0.6384},{"period":"ytd","weight":0.5426}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Solid Biosciences Inc.前称是“SOLID Ventures Management, LLC”,成立于2013年3月,最初是作为一家特拉华州有限责任公司成立的。该公司是一家生命科学公司,专注于推进当前和未来基因治疗候选药物组合,该公司将其统称为候选药物,包括用于治疗杜氏肌营养不良症的SGT-003,或Duchenne,用于治疗儿茶酚胺能多形性室性心动过速(CPVT)的SGT-501,以及用于治疗心脏和疾病的额外资产,处于不同的发展阶段,投资水平不同。该公司正在推进涉及罕见神经肌肉和心脏疾病的多样化管道,汇集科学、技术、疾病管理和护理方面的专家。以患者为中心,由直接受到Duchenne影响的人创立,该公司的使命是改善患有这些毁灭性疾病的患者的日常生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.034906},{"month":2,"riseRate":0.444444,"avgChangeRate":0.028361},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.100699},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.016391},{"month":5,"riseRate":0.555556,"avgChangeRate":0.036713},{"month":6,"riseRate":0.555556,"avgChangeRate":0.126637},{"month":7,"riseRate":0.444444,"avgChangeRate":0.054246},{"month":8,"riseRate":0.444444,"avgChangeRate":0.01425},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.071291},{"month":10,"riseRate":0.25,"avgChangeRate":-0.04082},{"month":11,"riseRate":0.625,"avgChangeRate":-0.055728},{"month":12,"riseRate":0.5,"avgChangeRate":0.250324}],"exchange":"NASDAQ","name":"Solid Biosciences","nameEN":"Solid Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Solid Biosciences(SLDB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Solid Biosciences(SLDB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Solid Biosciences,SLDB,Solid Biosciences股票,Solid Biosciences股票老虎,Solid Biosciences股票老虎国际,Solid Biosciences行情,Solid Biosciences股票行情,Solid Biosciences股价,Solid Biosciences股市,Solid Biosciences股票价格,Solid Biosciences股票交易,Solid Biosciences股票购买,Solid Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Solid Biosciences(SLDB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Solid Biosciences(SLDB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}